These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 6376948)

  • 1. Analytical specificity of commercially available methods for serum phenytoin determination.
    Haughey DB; Matzke GR; Halstenson CE; Keane WF
    J Anal Toxicol; 1984; 8(3):106-11. PubMed ID: 6376948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contribution of 5-(4-hydroxyphenyl)-5-phenylhydantoin to the discrepancy between phenytoin analyses by EMIT and high-pressure liquid chromatography.
    Sawchuk RJ; Matzke GR
    Ther Drug Monit; 1984; 6(1):97-103. PubMed ID: 6369645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of total and free phenytoin in serum by non-isotopic immunoassays and gas chromatography.
    Külpmann WR; Gey S; Beneking M; Kohl B; Oellerich M
    J Clin Chem Clin Biochem; 1984 Nov; 22(11):773-9. PubMed ID: 6396367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Nephelometric inhibition immunoassay (NIIA), a new methodology for the determination of phenobarbital and phenytoin concentration in serum (author's transl)].
    Liappis N
    Klin Padiatr; 1982 Mar; 194(2):88-90. PubMed ID: 7047885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluorescence polarization immunoassay IV. Determination of phenytoin and phenobarbital in human serum and plasma.
    Lu-Steffes M; Pittluck GW; Jolley ME; Panas HN; Olive DL; Wang CH; Nystrom DD; Keegan CL; Davis TP; Stroupe SD
    Clin Chem; 1982 Nov; 28(11):2278-82. PubMed ID: 6751601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative determination of phenytoin in plasma by fluorescence polarization immunoassay and high performance liquid chromatography.
    Othman S; al-Turk WA; Awidi AS; Daradkeh TK; Shaheen O
    Drug Des Deliv; 1987 Sep; 2(1):41-7. PubMed ID: 3334544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated serum phenytoin concentrations in a uremic patient when measured by enzyme-multiplied immunoassay.
    Matzke GR; Sawchuk RJ
    Drug Intell Clin Pharm; 1981 May; 15(5):386-8. PubMed ID: 7023901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interference in immunoassay measurements of total and free phenytoin in uremic patients: a reappraisal.
    Roberts WL; Rainey PM
    Clin Chem; 1993 Sep; 39(9):1872-7. PubMed ID: 8375063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparison of i-PiT, TDX and EMIT measurement of serum phenytoin and digoxin levels].
    Koizumi F; Kumai M; Ishimori A
    Rinsho Byori; 1985 Jul; 33(7):761-70. PubMed ID: 3906186
    [No Abstract]   [Full Text] [Related]  

  • 10. Phenytoin immunoassay measurements in serum samples from patients with renal insufficiency: comparison with high-performance liquid chromatography.
    Tutor-Crespo MJ; Hermida J; Tutor JC
    J Clin Lab Anal; 2007; 21(2):119-23. PubMed ID: 17385679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum creatinine concentration and the discrepancy between enzyme multiplied immunoassay technique and gas-liquid chromatographic phenytoin levels.
    Apple FS; Walker FC; Dietzler DN
    Ann Clin Lab Sci; 1983; 13(5):385-92. PubMed ID: 6357047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous quantitative assay of phenobarbital, phenytoin, and p-hydroxydiphenylhydantoin by HPLC and a comparison with EMIT.
    Couri D; Suarez del Villar C; Toy-Manning PT
    J Anal Toxicol; 1980; 4(5):227-31. PubMed ID: 7003258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interpretation of serum phenytoin concentrations in uremia is assay-dependent.
    Sirgo MA; Green PJ; Rocci ML; Vlasses PH
    Neurology; 1984 Sep; 34(9):1250-1. PubMed ID: 6540413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substrate-labeled fluorescent immunoassay for phenytoin in human serum.
    Wong RC; Burd JF; Carrico RJ; Buckler RT; Thoma J; Boguslaski RC
    Clin Chem; 1979 May; 25(5):686-91. PubMed ID: 108033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenytoin free fraction determination: comparison of an improved direct serum injection high-performance liquid chromatographic method to ultrafiltration coupled with fluorescence polarization immunoassay.
    Gurley BJ; Marx M; Olsen K
    J Chromatogr B Biomed Appl; 1995 Aug; 670(2):358-64. PubMed ID: 8548029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Competitive rate nephelometric immunoassay for determination of theophylline, phenobarbital, and dilantin in serum.
    Lee JH
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1982 Aug; 15(3):245-9. PubMed ID: 6754287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of serum phenytoin determination by the substrate-labeled fluorescent immunoassay with gas chromatography, liquid chromatography, radioimmunoassay and "EMIT".
    Wong RC; George R; Yeung R; Burd JF
    Clin Chim Acta; 1980 Jan; 100(1):65-9. PubMed ID: 6985851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A critical evaluation of a new fluorescence immunoassay system for the measurement of serum phenytoin concentrations.
    Davis SJ; Marks V
    Ann Clin Biochem; 1983 Sep; 20 (Pt 5)():274-9. PubMed ID: 6360026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Results by fluorescent immunoassay for phenytoin compared with those by enzyme immunoassay, liquid chromatography, and discrete analysis (Dupont aca).
    Gonzalez G; Cid-Amador A; Steele B; Castro A
    Clin Chem; 1982 Jul; 28(7):1494-6. PubMed ID: 7044616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Falsely increased immunoassay measurements of total and unbound phenytoin in critically ill uremic patients receiving fosphenytoin.
    Roberts WL; De BK; Coleman JP; Annesley TM
    Clin Chem; 1999 Jun; 45(6 Pt 1):829-37. PubMed ID: 10351992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.